Effects of PEMF on a murine osteosarcoma cell line: Drug-resistant (P-glycoprotein-positive) and non-resistant cells

Bioelectromagnetics

Volumn 21, Issue 2, 2000, Pages 112-121

  Miyagi, Norifumi ^b   Sato, Keiji ^b   Rong, Yuan ^b   Yamamura, Shigeki ^b   Katagiri, Hirohisa ^b   Kobayashi, Kenji ^b   Iwata, Hisashi ^a,b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Differentiation; Doxorubicin(ADR); Osteosarcoma; P glycoprotein; PEMF

Indexed keywords

CELL CULTURE; CLONE CELLS; GLYCOPROTEINS;

ADRIAMYCIN; DIFFERENTIATION; DOXORUBICIN; DOXORUBICIN(ADRIAMYCIN); EXPOSED TO; OSTEOSARCOMA CELLS; OSTEOSARCOMAS; P-GLYCOPROTEIN; PULSING ELECTROMAGNETIC FIELD; RESISTANT CELLS;

ELECTROMAGNETIC FIELDS;

DOXORUBICIN; GLYCOPROTEIN P;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIVISION; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECT; ELECTROMAGNETIC FIELD; FIBROBLAST; HUMAN; METABOLISM; MULTIDRUG RESISTANCE; OSTEOSARCOMA; RADIATION EXPOSURE;

ANIMALS; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; ELECTROMAGNETIC FIELDS; FIBROBLASTS; HUMANS; OSTEOSARCOMA; P-GLYCOPROTEIN; TUMOR CELLS, CULTURED;

EID: 0034133666     PISSN: 01978462     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-186X(200002)21:2<112::AID-BEM6>3.0.CO;2-H     Document Type: Article

References (48)

1. Andrew C, Bassett L. 1984. The development and application of pulsed electromagnetic fields (PEMF) for ununited fractures and arthrodeses. Orthop Clinics of North America 15:61-87.
2. Baserga R. 1965. The relationship of the cell cycle to tumor growth and control of cell division: A review. Cancer Res 25:581.
3. Baserga R. 1981. The cell cycle. N Engl J Med 304:453.
4. Bassett CAL, Mitchell BS, Gaston SR. 1981. Treatment of ununited tibial diaphyseal fractures with pulsing electromagnetic fields. J Bone Joint Surg [Am] 63-A-4: 511-523.
5. Bell DF, Bell RS, Mankin HJ, Gebhardt MC, Weltie F, O'Brien T. 1988. Kinetic effects of adriamycin and bleomycin on two osteosarcoma models. J Orthop Res 6(1):51-57.
6. Bourhis J, Benard J, Hartmann O, Boccon-Gibod L, Lemerle J, Riou G. 1989. Correlation of MDR1 gene expression with chemotherapy in neuroblastoma. J Nat Cancer Inst 81: 1401-1405.
7. Cadossi R, Ceccherelli GB, Emilia G, Torelli G, Ruggieri MP. 1988. The effects of low frequency pulsing electromagnetic fields on the response of human lymphocytes to lectins. Bioelectrochemistry and Bioenergetics 19:315-322.
8. Cartwright RA. 1989. Low frequency alternating electromagnetic fields and leukaemia: The saga so far. Br J Cancer 60: 649-651.
9. Chabner BA, Collins JM. 1990. Cancer chemotherapy. Principles and Practice. Philadelphia: Lippincott.
10. Chan HS, Haddad G, Thorner PS, DeBoer G, Lin YP, Ondrusek N, Yeger H, Ling V. 1991. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. New England J MED 325:1608-1614.
11. Chan HS, Thorner PS, Haddad G, DeBoer G, Ling V. 1990. Multidrug resistance in sarcomas of children. Frontiers of Osteosarcoma Research: Interdisciplinary Survey of Clinical and Research Advances, pp 51-63.
12. Chan HS, Thorner PS, Haddad G, Ling V. 1990. Immunohistochemical detection of P-glycoprotein: Prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 8:689-704.
13. Charles SM, Kenneth HC. 1990. Glutathione S-transferase and drug resistance. Cancer Cells 2:15-22.
14. Chen CJ, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Roninson IB. 1986. Internal duplication and homology with bacterial transport proteins in the MDR1 (P-glycoprotein) gene from multidrug resistant human cells. Cell 47: 381-389.
15. Cole SP, Chanda ER, Dicke FP, Gerlach JH, Mirski SE. 1991. Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: Evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II. Cancer Res 51:3345-3352.
16. Conti P, Gigante GE, Alesse E, Cifone MG, Fieschi C, Reale M, Angeletti PU. 1985. Effect of electromagnetic fields on two calcium dependent biological systems. J Bioelectricity 4:227-236.
17. Cossarizza A, Monti D, Bersani F, Cantini M, Cadossi R, Sacchi A, Franceschi C. 1989. Extremely low frequency pulsed electromagnetic fields increase cell proliferation in lymphocytes from young and aged subjects. Biochem Biophys Res Commun 160:692-698.
18. Date M, Kaneko I, Fukada E. 1986. Pulse magnetic stimulator for biological systems. Sci Papers IPCR 80:11-16.
19. Emilia G, Torelli G, Ceccherelli G, Donelli A, Ferrari S, Zucchini P, Cadossi R. 1985. Effect of low-frequency low-energy pulsing electromagnetic fields on the response to lectin stimulation of human normal and chronic lymphocytic leukemia lymphocytes. J Bioelectricity 4:145-161.
20. Fairchild CR, Ivy SP, Kao-Shan CS, Whang-Peng J, Rosen N, Israel MA, Melera PW, Cowan KH, Goldsmith ME. 1987. Isolation of amplified and overexpressed DNA sequences from Adriamycin-resistant human breast cancer cells. Cancer Res 47:5141-5148.
21. Fitzsimmons RJ, Strong DD, Mohan S, Baylink DJ. 1992. Low-amplitude, low-frequency electric field-stimulated bone cell proliferation may in part be mediated by increased IGF-II release. J Cellular Physiology 150:84-89.
22. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. 1987. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Nat Acad Sci 84:265-269.
23. Friedman MA, Carter SK. 1972. The therapy of osteogenic sarcoma: Current status and thoughts for the future. J Surg Oncol 4:482-510.
24. Gerlach JH, Endicott JA, Juranka PF, Henderson G, Sarangi F, Deuchars KL, Ling V. 1986. Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature 324: 485-489.
25. Giavazzi R, Kartner N, Hart IR. 1984. Expression of cell surface P-glycoprotein by an Adriamycin-resistant murine fibrosarcoma. Cancer Chemother and Pharmacol 13:145-147.
26. Goodman R, Henderson AS. 1986. Sine waves enhance cellular transcription. Bioelectromagnetics 7:23.
27. Hahn GM, Braun J, Har-Kedar I. 1975. Thermochemotherapy: Synergism between hyperthermia(42C-43C) and adriamycin(or bleomycin) in mammalian cell inactivation. Proc Natl Acad Sci USA 72:937-940.
28. Hansen MB, Nielsen SE, Berg K. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunological Methods 119:203-210.
29. Kanamori M, Matsui H, Yudoh K, Maeda A, Kadowaki KM, Tsuji H, Ochiai H, Tatezaki S. 1993. Differentiation of Dunn osteosarcoma cells in response to dibutyryl cyclic adenosine monophosphate. J Cancer Res Clin oncol 119(6):323-328.
30. Kartner H, Riordan JR, Ling V. 1983. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 221:1285-1288.
31. Liboff AR, Williams T, Strong DM, Wister R. 1984. Time-varying magnetic fields: Effect on DNA synthesis. Science 223: 818-819.
32. Link MP. 1993. Preoperative and adjuvant chemotherapy in osteosarcoma. Frontiers of Osteosarcoma Research: Interdisciplinary Survey of Clinical and Research Advances. pp 41-49.
33. Omote Y. 1988. An experimental attempt to potentiate therapeutic effects of combined use of pulsing magnetic fields and antitumor agents. Jpn Surg Soc 89:1155-1166 (Japanese).
34. Omote Y, Hosokawa M, Komatsumoto M, Namieno T, Nakajima S, Kubo Y, Kobayashi H. 1990. Treatment of experimental tumors with a combination of a pulsing magnetic fields and an antitumor drug. Jpn J Cancer Res 81:956-961.
35. Oosaki Y. 1982. Studies on the tissue culture of murine sarcoma(Dunn sarcoma)-a fix cell line established in vitro(DSK) and its cytokinetic findings. J Jpn Orthop Asso 56(1):37-49 (Japanese).
36. Pasquinelli P, Petrini M, Mattii L, Galimberti S, Saviozzi M, Malvaldi, G 1993. Biological effects of PEMF (Pulsing Electromagnetic Fields): An attempt to modify cell resistance to anticancer agents. J Environmental Pathol Toxicol Oncol 12(4):193-197. Pastan I, Gottesman M. 1987. Multiple-drug resistance in human cancer. New England J Med 316:1388-1393.
37. Pasquinelli P, Petrini M, Mattii L, Galimberti S, Saviozzi M, Malvaldi, G 1993. Biological effects of PEMF (Pulsing Electromagnetic Fields): An attempt to modify cell resistance to anticancer agents. J Environmental Pathol Toxicol Oncol 12(4):193-197. Pastan I, Gottesman M. 1987. Multiple-drug resistance in human cancer. New England J Med 316:1388-1393.
38. Pastan I, Gottesman M. 1987. Multiple-drug resistance in human cancer. New England J Med 316:1388-1393.
39. Petrini M, Mattii L, Sabbatini A, Carulli G, Grassi B, Cadossi R, Ronca G, Conte A. 1990. Multidrug resistance and electromagnetic fields. J Bioelectricity 9:209-212.
40. Rodan GA, Bourret LA, Norton LA. 1978. DNA synthesis in cartilage cells is stimulated by oscillating electric fields. Science 199:690-692.
41. Saracci R. 1981. The IARC monograph program on the evaluation of the carcinogenic risk of chemicals to humans as a contribution of occupational carcinogens. In: Peto R, Schneiderman M, editors. Banbury report 9: Quantification of occupational cancer. Cold Habor: Cold Spring Habor Laboratory. :65-176.
42. Shaeffer J, EL-Mahdi AM. 1981. Combination adriamycinradiation treatment of pulmonary tumors in mice. Oncology 38(1):35-38.
43. Shore RE. 1988. Electromagnetic radiations and cancer: Cause and prevention. Cancer 62(suppl):1747-1754.
44. Takahashi K, Kaneko I, Date M, Fukada E. 1985. Effect of pulsing electromagnetic fields on DNA synthesis in mammalian cells in culture. Experientia 42:185-186.
45. Takeshita H, Gebhardt MC, Springfield DS, Kusuzaki K, Mankin HJ. 1996. Experimental models for the study of drug resistance in osteosarcoma. J Bone Joint Surg [Am] 78: 366-375.
46. Tanaka H, Yamamoto T, Kotoura Y, Matsumoto M, Tanaka C, Suzuki S, Tsuzi T, Miki T. 1989. 1 alpha, 25 (OH)2D3 exerts cytostatic effects on murine osteosarcoma cells and enhances the cytocidal effects of anticancer drugs. Clin Orthop 247:290-296.
47. Timmer-Bosscha H, Hospers GA, Meijer NH, Muskiet FA, Martini IA, Uges DR, de Vries EG. 1989. Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell line. J Nat Cancer Inst 81:1069-1075.
48. Tsuda T, Masuhara K, Toshikawa H, Shimizu N, Takaoka K. 1989. Establishment of an osteoinductive murine osteosarcoma clonal cell line showing osteoblastic phenotypic traits. Bone 10(3):195-200.